Yüklüyor......
Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis
PURPOSE: This study aimed to characterize the prescribing of dalfampridine extended release (D-ER) 10 mg tablet treatment in people with multiple sclerosis (MS). METHODS: A retrospective cohort study was performed using Medco pharmacy and medical claims. Medical claims were used to identify MS patie...
Kaydedildi:
| Yayımlandı: | Ther Clin Risk Manag |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4274131/ https://ncbi.nlm.nih.gov/pubmed/25565851 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S75837 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|